# Venture Capital Multiplier Fund

> Venture Capital Multiplier Fund is a VC fund backing Fitness, Wellness and Biopharma. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Apr 2020
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/hatteras-venture-partners
- Website: http://hatterasvp.com/venture-capital-multiplier-fund/

Venture Capital Multiplier Fund is a venture capital firm

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Fitness | 1 | 33% |
| Wellness | 1 | 33% |
| Biopharma | 1 | 33% |
| Nutrition | 1 | 33% |
| Health Care | 1 | 33% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Seed | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Panaceutics Nutrition | Panaceutics Nutrition is a company that produces individually customized smoothies with proprietary cost-effective robotic technology. The company was founded in 2018 by Edison Hudson and Staton Noel and is based in Ringgold, Virginia, United States. | $5M | Series A | Apr 20, 2020 |  |
| Howso | The company's mission focuses on establishing trustworthy AI as the global standard by redesigning it from the ground up, ensuring transparency and human comprehensibility in every aspect.Howso is an AI-driven platform designed to assist enterprises in preparing and analyzing data for AI use cases. This is achieved through the UnderstandableAI® Platform—a data-centric AI solution offering a clear alternative to traditional neural networks.Howso (formerly “Diveplane”) was co-founded by Dr. Mike Capps, Dr. Chris Hazard, and Mike Resnick in 2017. In September 2023, the company rebranded to Howso, alongside the release of our open source project. |  | Seed | Oct 16, 2018 |  |
| Emergo Therapeutics | Emergo Therapeutics is a pharmaceutical startup that develops treatment options for flu-like illnesses. It is focused on developing drugs to modulate inflammatory cytokines and improve the functioning of the immune system in various potential indications, starting with infectious diseases. Emergo’s therapeutic interventions are focused on reducingthe production of inflammatory cytokines from mast cells.Emergo is headquartered in Durham, North Carolina. | $12M | Series A | May 23, 2018 |  |

3 of 3 investments shown.

## Co-investors
- [Wolfpack Investor Network](https://shizune.co/investors/profile/wolfpack-investor-network) — VC Fund, 2 deals together
- [Carolina Angel Network](https://shizune.co/investors/profile/carolina-angel-network) — VC Fund, 1 deal together
- [Virginia Venture Partners](https://shizune.co/investors/profile/cit-gap-funds) — VC Fund, 1 deal together
- [DSM Venturing](https://shizune.co/investors/profile/dsm-venturing) — VC Fund, 1 deal together
- [Ironwood Ventures](https://shizune.co/investors/profile/ironwood-ventures-2a2e) — VC Fund, 1 deal together
- [Presence Capital](https://shizune.co/investors/profile/presence-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Venture Capital Multiplier Fund invest in?

Venture Capital Multiplier Fund invests primarily in Fitness, Wellness and Biopharma startups, most often at Series A and Seed stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Venture Capital Multiplier Fund last invest?

The most recent investment recorded for Venture Capital Multiplier Fund closed in Apr 2020. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co